BridgeBio Oncology Therapeutics, Inc.
Balance Sheet
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Assets | |||
| Cash & Equivalents | $1.8M | $1.8M | $250.0K |
| Accounts Receivable | — | — | — |
| Inventory | — | — | — |
| Total Current Assets | $2.1M | $2.1M | — |
| Property, Plant & Equipment | — | — | — |
| Goodwill | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — |
| Total Assets | $189.9M | $187.5M | $332.9K |
| Liabilities | |||
| Accounts Payable | — | — | — |
| Total Current Liabilities | $79.1K | $23.3K | $396.5K |
| Long-Term Debt | — | — | — |
| Total Liabilities | $5.6M | $5.5M | $396.5K |
| Stockholders' Equity | |||
| Retained Earnings | $-3.4M | $-3.2M | $-88.6K |
| Total Stockholders' Equity | $-143.4M | $-128.9M | $-115.6M |